Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Albrecht

Showing results (161-170 of 245) with videos related to

Pageof 25
Sort By:
Jvs-Vascular Science|December 11, 2023
Aortic dissection detection and thrombus structure quantification using volumetric ultrasound, histology, and scanning electron microscopyLuke E Schepers, Irina N Chernysh, Claudia K Albrecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBallachanda N Devaiah, Brian A Lewis, Natasha Cherman, et al.
Histochemistry and Cell Biology|October 11, 2020
Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticlesE A Wallnöfer, G C Thurner, C Kremser, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
Gastroenterology|October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis CJohn G McHutchison, Michael Manns, Keyur Patel, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 26, 2016
Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus InfectionBarbara Haber, Estella Alonso, Alejandra Pedreira, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Zeitschrift Fur Rheumatologie|August 13, 2024
[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024]J Braun, K Albrecht, J Callhoff, et al.
BMC Musculoskeletal Disorders|November 14, 2023
Supplementary orthopaedic screening for children and adolescents to prevent permanent skeletal deformities - protocol for the "OrthoKids" studyB Scheckel, M Naumann, D Simic, et al.
Pageof 25

Showing results (161-170 of 245) with videos related to

Sort By:
Pageof 25
Jvs-Vascular Science|December 11, 2023
Aortic dissection detection and thrombus structure quantification using volumetric ultrasound, histology, and scanning electron microscopyLuke E Schepers, Irina N Chernysh, Claudia K Albrecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2012
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domainBallachanda N Devaiah, Brian A Lewis, Natasha Cherman, et al.
Histochemistry and Cell Biology|October 11, 2020
Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticlesE A Wallnöfer, G C Thurner, C Kremser, et al.
Lancet (London, England)|October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialM P Manns, J G McHutchison, S C Gordon, et al.
Gastroenterology|October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis CJohn G McHutchison, Michael Manns, Keyur Patel, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 26, 2016
Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus InfectionBarbara Haber, Estella Alonso, Alejandra Pedreira, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupJ G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Zeitschrift Fur Rheumatologie|August 13, 2024
[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024]J Braun, K Albrecht, J Callhoff, et al.
BMC Musculoskeletal Disorders|November 14, 2023
Supplementary orthopaedic screening for children and adolescents to prevent permanent skeletal deformities - protocol for the "OrthoKids" studyB Scheckel, M Naumann, D Simic, et al.
Pageof 25